Clinical trial
Once Weekly Parathyroid Hormone for Osteoporosis
NCT00065637 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00065637 |
|---|---|
| Title | Once Weekly Parathyroid Hormone for Osteoporosis |
| Official title | PTH Once Weekly Research (POWR) |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteopenia, Osteoporosis |
| Intervention type | Drug |
| Interventions | Teriparatide, Placebo teriparatide |
| Enrollment | 50 |
| Start date | Dec 1, 2003 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Jul 30, 2003 |
| Last update posted | Feb 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: